Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CANCER,NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT00326599
What this trial is testing

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT05610332
What this trial is testing

Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

Who this might be right for
Locally Advanced Gastric Cancer
Fujian Medical University 216
Not applicableStudy completedNCT00802932
What this trial is testing

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 61
Not applicableLooking for participantsNCT05890287
What this trial is testing

Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

Who this might be right for
HR Positive HER2 Negative Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07214987
What this trial is testing

PDT For Induction Therapy For Head And Neck Cancer

Who this might be right for
Squamous Cell CarcinomaHead and Neck Cancer Squamous Cell CarcinomaHead and Neck Cancer
Massachusetts General Hospital 26
Not applicableNot Yet RecruitingNCT07490093
What this trial is testing

Adaptation Strategies for Coping With the Impact of Sensory Alterations on Eating Behavior in Children With Cancer: A Qualitative Study From the Perspective of Children and Parents

Who this might be right for
Taste AlterationsSmell DisorderEating Behavior Changes
Centre Leon Berard 30
Testing effectiveness (Phase 2)Study completedNCT04951921
What this trial is testing

Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy

Who this might be right for
Cervical Cancer
Chang Gung Memorial Hospital 6
Testing effectiveness (Phase 2)Study completedNCT00186121
What this trial is testing

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

Who this might be right for
Breast Cancer
Stanford University 35
Early research (Phase 1)Not Yet RecruitingNCT06203821
What this trial is testing

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Aram Hezel 25
Testing effectiveness (Phase 2)Looking for participantsNCT06971614
What this trial is testing

T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Who this might be right for
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd 160
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Very early researchStudy completedNCT00743314
What this trial is testing

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Who this might be right for
Breast CancerLymphedema
Mayo Clinic 30
Not applicableStudy completedNCT04330716
What this trial is testing

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 269
Early research (Phase 1)Study completedNCT00706316
What this trial is testing

Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer

Who this might be right for
Nasopharyngeal Cancer
University Health Network, Toronto 5
Early research (Phase 1)Study completedNCT03578406
What this trial is testing

HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer

Who this might be right for
Cervical CancerHead and Neck Squamous Cell Carcinoma
Xinqiao Hospital of Chongqing 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484
What this trial is testing

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more
Revolution Medicines, Inc. 590
Testing effectiveness (Phase 2)Study completedNCT03081858
What this trial is testing

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder Cancer+7 more
Lipac Oncology LLC 15
Testing effectiveness (Phase 2)Study completedNCT01874938
What this trial is testing

LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Eli Lilly and Company 15
Next Page